scholarly journals Implantable Cardioverter-defibrillator Use in Structural Heart Disease: Narrowing the Playing Field

2018 ◽  
Vol 9 (2) ◽  
pp. 3033-3034
Author(s):  
Christopher Ellis
Keyword(s):  
Heart Disease ◽  
Implantable Cardioverter Defibrillator ◽  
Structural Heart Disease ◽  
Cardioverter Defibrillator ◽  
Playing Field

Identification of High-risk Patients for Implantable Cardioverter–Defibrillator Therapy in Asia

2011 ◽  
Vol 3 (1) ◽  
pp. 77
Author(s):  
Cyril YK Ko ◽  
Jeffrey WH Fung ◽  
◽  
Keyword(s):  
Heart Disease ◽  
Implantable Cardioverter Defibrillator ◽  
Asian Population ◽  
Structural Heart Disease ◽  
Medical Problem ◽  
Western World ◽  
Asian Countries ◽  
Cardioverter Defibrillator ◽  
Asian Patients ◽  
Risk Patients

Sudden cardiac death (SCD) is a serious medical problem worldwide. Multiple landmark studies have demonstrated the benefit of implantable cardioverter–defibrillator (ICD) therapy in preventing SCD in at-risk patients. Although the data available in Asia are limited, the disease pattern seems to be different from that in the western world. The Asian population seems to have a lower incidence of SCD. Coronary heart disease, which is the major underlying cause of SCD in the west, may play a less important role in Asian countries. In addition, non-structural heart disease seems to be a more prevalent cause of SCD in Asia. It is thus questionable whether the results of ICD trials can be applied directly to Asian countries, as most of these trials seldom recruited Asian patients. This article will review SCD in Asia, focusing on the epidemiology and risk factors for SCD in Asia and highlighting some unique features that may be different from those seen in the western world.

scholarly journals Relationship between Fragmented QRS Complexes and Implantable Cardioverter Defibrillator Use in Patients with Structural Heart Disease

2011 ◽  
Vol 27 (Supplement) ◽  
pp. PJ3_049
Author(s):  
Makoto Takano ◽  
Harada Tomoo ◽  
Nishio Satoru ◽  
Matsumoto Naoki ◽  
Yoshihiro J. Akashi ◽  
...  
Keyword(s):  
Heart Disease ◽  
Implantable Cardioverter Defibrillator ◽  
Structural Heart Disease ◽  
Cardioverter Defibrillator ◽  
Fragmented Qrs

scholarly journals Recent advances in the management of ventricular tachyarrhythmias

F1000Research ◽  
2017 ◽  
Vol 6 ◽  
pp. 1027 ◽  
Author(s):  
Syeda Atiqa Batul ◽  
Brian Olshansky ◽  
John D. Fisher ◽  
Rakesh Gopinathannair
Keyword(s):  
Heart Disease ◽  
Implantable Cardioverter Defibrillator ◽  
Ventricular Arrhythmias ◽  
Symptom Relief ◽  
Structural Heart Disease ◽  
Left Ventricular ◽  
Cardioverter Defibrillator ◽  
Arrhythmic Death ◽  
Recent Advances ◽  
Cardiovascular Morbidity And Mortality

Ventricular arrhythmias are an important cause of cardiovascular morbidity and mortality, particularly in those with structural heart disease, inherited cardiomyopathies, and channelopathies. The goals of ventricular arrhythmia management include symptom relief, improving quality of life, reducing implantable cardioverter defibrillator shocks, preventing deterioration of left ventricular function, reducing risk of arrhythmic death, and potentially improving overall survival. Guideline-directed medical therapy and implantable cardioverter defibrillator implantation remain the mainstay of therapy to prevent sudden cardiac death in patients with ventricular arrhythmias in the setting of structural heart disease. Recent advances in imaging modalities and commercial availability of genetic testing panels have enhanced our mechanistic understanding of the disease processes and, along with significant progress in catheter-based ablative therapies, have enabled a tailored and more effective management of drug-refractory ventricular arrhythmias. Several gaps in our knowledge remain and require further research. In this article, we review the recent advances in the diagnosis and management of ventricular arrhythmias.

Sign in / Sign up

Export Citation Format

Share Document